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684 The Journal of Thoracic and CardioObjective: A femoral artery cannula is used for certain types of circulatory support
but can cause ischemia, especially during prolonged perfusion. This study tests the
function of a femoral cannula designed to allow proximal and distal blood flow.
Methods: Five pigs were used in the study. In each animal a distal-flow cannula was
implanted in the femoral artery of one leg, and the same-sized standard cannula was
implanted in the other. Blood was drained from the left atrium and delivered to the
femoral artery through the distal-flow cannula or standard cannula by using a
centrifugal pump. An ultrasonic flow probe and microspheres were used to quantify
flow and perfusion distal to the cannula.
Results: Distal femoral flow and tissue perfusion were present in all animals (5/5)
with the distal-flow cannula but only in 1 of 5 animals with the standard cannula (P
 .048). Distal flow did not change with pump flow. Mean distal flow at each level
of pump flow was higher with the distal-flow cannula (P  .05). Tissue perfusion
was also higher with the distal-flow cannula (0.052  0.028 vs 0.010  0.022
mL · min1 · g1, P  .03).
Conclusions: In the swine model the distal-flow cannula allowed greater and more
consistent distal flow than the standard cannula. The use of a distal-flow cannula for
circulatory support might reduce the risk of distal limb ischemia.
There are circumstances in which femoral cannulation is used during cardio-pulmonary bypass or mechanical circulatory support. Problems can occurwith this approach when the cannula occludes the femoral artery, resulting in
significant leg ischemia.1-3 If this problem develops, blood can be diverted from the
arterial line and delivered to the distal vessel by means of an additional cannula.4
This provides adequate distal flow but requires extra hardware and a second
puncture. A need exists for a single arterial cannula that allows both proximal and
distal blood flow. A distal-flow cannula (DFC) was proposed by Matsuura and
colleagues5 but was never commercialized. This report presents experimental data
on the functional performance of a new DFC cannula design.
Materials and Methods
This study was approved by the Institutional Animal Care and Use Committee of Allegheny-
Singer Research Institute. All procedures were performed in compliance with the “Guide for
the Care and Use of Laboratory Animals” prepared by the National Academy of Sciences and
published by National Academy Press (1996). Farm pigs (n  5) weighing 120 to 136 lbs
were used in the studies. The DFC is shown in Figure 1. This design incorporates a diverting
side hole, with 2 supporting rails next to the side hole that lift the cannula away from the
vessel wall, allowing blood to flow past the cannula. A 2-stage obturator is used to ensure the
proper placement of the DFC. The tip of the obturator is larger in diameter than the proximal
shaft and occludes the section of the cannula from the tip to the side hole. The proximal shaft
end has a smaller diameter that leaves a hollow passage between the cannula wall and the
obturator. The resulting space is dubbed the “flash chamber” because it allows blood to “flash
back” when the diverting side hole enters the vessel. The proximal end of the DFC wall is
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Ptransparent for the purpose of visualizing the flash-back effect.
During DFC percutaneous insertion, the flash-back feature informs
the operator when the diverting hole enters the femoral artery,
which helps proper placement of the DFC.
The common femoral arteries were exposed by surgical means,
and lidocaine was applied to prevent vessel spasm. The vessel’s
outer diameter was measured with a caliper. A left thoracotomy
was performed to expose the left atrium. Activated clotting time
was measured and adjusted to around 400 seconds by administer-
ing heparin. A 24F venous return cannula (DLP Single Stage
Venous Cannula; Medtronic, Grand Rapids, Mich) was placed in
the left atrial appendage. The Seldinger technique was then used to
cannulate the femoral artery, rather than an arteriotomy, to avoid
bleeding around the cannula. No pursestring suture, ligature
around the artery, or occlusion of the distal vessel was done in
either group of animals. A TandemHeart percutaneous ventricular
assist device (CardiacAssist, Inc, Pittsburgh, Pa) was used to pump
the blood from the left atrium to the femoral artery at a flow of 1.0
to 3.5 L/min. A Transonic flow probe (5SB Perivascular Flow-
probe; Transonic Systems, Inc, Ithaca, NY) was placed around the
femoral artery distal to the cannula insertion site. The performance
of the DFC was compared with that of a standard cannula (SC) in
2 sequential experiments, which were identical except for the order
in which the cannulas were tested. First, either the DFC or the SC
was inserted, tested, and removed. Then the other cannula was
inserted, tested, and removed. The order for inserting the cannulas
was randomized. The cannulas were each secured to the skin with
sutures to prevent movement during the experiments.
Figure 1. The important features of the DFC are shown. The end
of the cannula has an end hole and multiple side holes. The distal
flow port has 2 rails surrounding a side hole. The rails keep the
cannula away from the vessel wall, allowing blood to flow past
the cannula.
TABLE 1. Distal femoral flow with the DFC and SC at diffe
1.0 L/min 1.5 L/min 2.0 L/m
Animal 1 DFC 10 10 10
SC 0 0 0
Animal 2 DFC 70 70 70
SC 0 0 0
Animal 3 DFC 80 73 75
SC 0 0 0
Animal 4 DFC 76 78 80
SC 0 0 0
Animal 5 DFC 86 84 83
SC 49 43 82
Mean DFC 64  31* 63  30* 64 
SC 10  22 9  19 16 Flow is measured as milliliters per minute. DFC, Distal-flow cannula; SC, standa
The Journal of ThoraciDistal leg tissue perfusion was quantified with a neutron-
activated microsphere technique.6 For each leg, a 5-mL volume of
microspheres (BioPhysics Assay Laboratory, Inc, Worcester,
Mass) was injected at a speed of 5 mL over 30 seconds through the
side port of the cannula at a pump flow rate of 3.50 L/min.
Microspheres of different intensity were used for each infusion.
After the experiment, calf muscles from each leg were excised to
yield 2 replicate samples weighing about 1 g each. The samples
were dried and sent to BioPal for microsphere concentration quan-
tification and calculation of tissue perfusion. Each animal experi-
ment took approximately 3 hours, 1 hour for surgical exposure and
instrumentation and 2 hours for the cannula studies (1 hour for
each).
A section of femoral artery around the cannula insertion site
was excised for explant analysis. The vessels were opened longi-
tudinally on the side opposite to the puncture hole. Samples were
examined with a microscope for intimal tears or tears at the
puncture site.
The data were analyzed by using 2 statistical tests. The pres-
ence or absence of flow and perfusion was compared with a
2-tailed Fisher’s exact test. The magnitude of flow and tissue
perfusion for the 2 groups were compared with paired t tests.
Results
The mean arterial diameter for vessels in which the DFC
and SC were used was 0.60  0.17 and 0.59  0.11 cm,
respectively. Mean baseline femoral flow in the vessels in
which the DFC and SC were used was 99 44 mL/min and
100  46 mL/min, respectively. Distal femoral artery flow
after cannulation is listed in Table 1. Distal femoral flow did
not change with increased pump flow. Flow was present in
5 of 5 animals with the DFC but in only 1 of 5 animals with
the SC (P  .024, 2-tailed Fisher’s exact test). The one
animal with distal flow with the SC had the largest baseline
vessel size (0.76 cm). Paired t tests showed higher flow
using the DFC than the SC at each level of flow (P  .05).
The tissue perfusion results are presented in Table 2.
Perfusion was measured at a pump flow of 3.5 L/min. Distal
pump flow rates
2.5 L/min 3.0 L/min 3.5 L/min Mean  SD
10 10 20 12  4
0 0 0 0
90 80 80 77  8
0 0 0 0
95 70 110 84  16
0 0 0 0
92 80 90 83  7
0 0 0 0
85 84 87 85  1
80 43 5 50  28
74  36* 65  31* 77  34*
16  36 9  19 1  2rent
in
30*
37rd cannula; SD, standard deviation. *DFC  SC, P  .05.
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.03). Evidence of tissue perfusion was found in 5 of 5
animals with the DFC but only in 1 of 5 animals with the SC
(P  .024).
The insertion of the DFC was no different than that of the
SC, except for positioning of the diverting hole with the
flash-back feature. Good flash-back visualizations were ob-
served during all DFC placement procedures. The same
length of cannula was inserted into the femoral artery for the
DFC and the SC. There was no difficulty in removing the
DFC. Explant analyses showed no intimal tears or thrombus
with either cannula.
Discussion
This study shows that the DFC allowed significant blood
flow distal to the cannulation site, whereas the same size SC
did not. In addition, distal blood was a consistent feature of
the DFC, which was measured in all animals, whereas the
SC showed no flow in most animals. The average distal flow
was approximately two thirds of baseline value. The micro-
sphere data confirmed this finding, showing no tissue per-
fusion in most animals with the SC and consistent perfusion
with the DFC. These data support the hypothesis that the SC
frequently caused mechanical obstruction of the vessel,
which was alleviated by the design of the DFC.
This was an experimental study that evaluated the con-
TABLE 2. Distal tissue perfusion with the DFC and SC
Tissue perfusion (mL · min1 · g1)
Animal DFC SC
1 0.049 0.000
2 0.086 0.000
3 0.050 0.050
4 0.064 0.000
5 0.010 0.000
Mean  SD 0.052  0.028* 0.010  0.022
DFC, Distal-flow cannula; SC, standard cannula; SD, standard deviation.
*DFC  SC, P  .05.cept of a DFC, but the ultimate goal is a commercial product
686 The Journal of Thoracic and Cardiovascular Surgery ● Septfor use by cardiac surgeons. Possible clinical indications
include extracorporeal membrane oxygenation, percutane-
ous left heart assistance, complex aortic arch operations,
and difficult redo sternotomy procedures.
There are limitations to the current study that warrant
consideration. All the animals had normal blood vessels,
whereas the patient population for this device might have
peripheral vascular disease, which could influence the per-
formance of the cannula. Therefore this study serves as
preliminary evidence, and further studies will be needed in
diseased vessels. Also, the duration of the experiments did
not exceed 4 hours. Studies of much longer duration will be
necessary to investigate the performance of the DFC in the
clinical setting. Despite these limitations, the current study
clearly demonstrates that the DFC provides greater distal
flow than an SC of the same size, providing a rationale for
development of a clinical DFC cannula.
We acknowledge the technical contributions made to this work
by Deborah Scalise, Katherine O’Callaghan, Tom Will, and the
staff of animal facility at Allegheny-Singer Research Institute,
Pittsburgh, Pa.
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